What the Research Says
Moringa oleifera has attracted growing research interest since the 2010s, with over 1,300 published studies — though the majority remain preclinical (in vitro or animal models). The strongest human evidence exists for blood glucose regulation: a 2016 clinical trial showed 4g of moringa leaf powder daily reduced fasting glucose by 28% over 40 days. Anti-inflammatory mechanisms are well-characterized in lab settings, with isothiocyanates (particularly moringin) demonstrating potent NF-κB inhibition. Cholesterol-lowering effects have been observed in several small trials, but large-scale RCTs are still needed. The plant's exceptional micronutrient density is well-documented, making it valuable for populations with nutritional deficiencies. Key limitations include small sample sizes, short study durations, and limited standardization of extracts across trials.